Click for best price
Super Generics Market Size, Share 2024
| Market size in 2023 |
US$ 73.06 billion
|
Forecast Market size by 2030 |
US$ 128.62 billion
|
| Growth Rate |
CAGR of 7.32% |
Number of Pages |
69 Pages |
The global Super Generics market was valued at US$ 73.06 billion in 2023 and is projected to reach US$ 128.62 billion by 2030, at a CAGR of 7.32% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The huge cost of drug development and the time overruns to develop new therapeutics have hindered innovation in the drug research and development space by promoting companies to find alternatives to maintain patent protection for a given brand. Super generics or modified therapeutic entities are an excellent form of a given generic drug molecule, which has better patient compliance and therapeutic effect than existing generic drugs.
This report aims to provide a comprehensive presentation of the global market for Super Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Super Generics. This report contains market size and forecasts of Super Generics in global, including the following market information:
- Global Super Generics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Super Generics include Sun Pharmaceutical Industries, Meda Pharmaceuticals, Taiwan Liposome Company, Dr. Reddys Laboratories, Allergan, Teva Pharmaceutical and Celgene Corporation, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Super Generics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Super Generics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Super Generics Market Segment Percentages, by Type, 2023 (%)
Global Super Generics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Super Generics Market Segment Percentages, by Application, 2023 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Super Generics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Super Generics Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Super Generics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Super Generics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sun Pharmaceutical Industries
- Meda Pharmaceuticals
- Taiwan Liposome Company
- Dr. Reddys Laboratories
- Allergan
- Teva Pharmaceutical
- Celgene Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Super Generics, market overview.
Chapter 2: Global Super Generics market size in revenue.
Chapter 3: Detailed analysis of Super Generics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Super Generics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Super Generics Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 73.06 billion
|
| Forecast Market size by 2030 |
US$ 128.62 billion
|
| Growth Rate |
CAGR of 7.32% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Super Generics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Super Generics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Super Generics Overall Market Size
2.1 Global Super Generics Market Size: 2022 VS 2030
2.2 Global Super Generics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Super Generics Players in Global Market
3.2 Top Global Super Generics Companies Ranked by Revenue
3.3 Global Super Generics Revenue by Companies
3.4 Top 3 and Top 5 Super Generics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Super Generics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Super Generics Players in Global Market
3.6.1 List of Global Tier 1 Super Generics Companies
3.6.2 List of Global Tier 2 and Tier 3 Super Generics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Super Generics Market Size Markets, 2022 & 2030
4.1.2 Oral
4.1.3 Injectable
4.1.4 Others
4.2 By Type - Global Super Generics Revenue & Forecasts
4.2.1 By Type - Global Super Generics Revenue, 2018-2023
4.2.2 By Type - Global Super Generics Revenue, 2024-2030
4.2.3 By Type - Global Super Generics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Super Generics Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Super Generics Revenue & Forecasts
5.2.1 By Application - Global Super Generics Revenue, 2018-2023
5.2.2 By Application - Global Super Generics Revenue, 2024-2030
5.2.3 By Application - Global Super Generics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Super Generics Market Size, 2022 & 2030
6.2 By Region - Global Super Generics Revenue & Forecasts
6.2.1 By Region - Global Super Generics Revenue, 2018-2023
6.2.2 By Region - Global Super Generics Revenue, 2024-2030
6.2.3 By Region - Global Super Generics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Super Generics Revenue, 2018-2030
6.3.2 US Super Generics Market Size, 2018-2030
6.3.3 Canada Super Generics Market Size, 2018-2030
6.3.4 Mexico Super Generics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Super Generics Revenue, 2018-2030
6.4.2 Germany Super Generics Market Size, 2018-2030
6.4.3 France Super Generics Market Size, 2018-2030
6.4.4 U.K. Super Generics Market Size, 2018-2030
6.4.5 Italy Super Generics Market Size, 2018-2030
6.4.6 Russia Super Generics Market Size, 2018-2030
6.4.7 Nordic Countries Super Generics Market Size, 2018-2030
6.4.8 Benelux Super Generics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Super Generics Revenue, 2018-2030
6.5.2 China Super Generics Market Size, 2018-2030
6.5.3 Japan Super Generics Market Size, 2018-2030
6.5.4 South Korea Super Generics Market Size, 2018-2030
6.5.5 Southeast Asia Super Generics Market Size, 2018-2030
6.5.6 India Super Generics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Super Generics Revenue, 2018-2030
6.6.2 Brazil Super Generics Market Size, 2018-2030
6.6.3 Argentina Super Generics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Super Generics Revenue, 2018-2030
6.7.2 Turkey Super Generics Market Size, 2018-2030
6.7.3 Israel Super Generics Market Size, 2018-2030
6.7.4 Saudi Arabia Super Generics Market Size, 2018-2030
6.7.5 UAE Super Generics Market Size, 2018-2030
7 Super Generics Companies Profiles
7.1 Sun Pharmaceutical Industries
7.1.1 Sun Pharmaceutical Industries Company Summary
7.1.2 Sun Pharmaceutical Industries Business Overview
7.1.3 Sun Pharmaceutical Industries Super Generics Major Product Offerings
7.1.4 Sun Pharmaceutical Industries Super Generics Revenue in Global Market (2018-2023)
7.1.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.2 Meda Pharmaceuticals
7.2.1 Meda Pharmaceuticals Company Summary
7.2.2 Meda Pharmaceuticals Business Overview
7.2.3 Meda Pharmaceuticals Super Generics Major Product Offerings
7.2.4 Meda Pharmaceuticals Super Generics Revenue in Global Market (2018-2023)
7.2.5 Meda Pharmaceuticals Key News & Latest Developments
7.3 Taiwan Liposome Company
7.3.1 Taiwan Liposome Company Company Summary
7.3.2 Taiwan Liposome Company Business Overview
7.3.3 Taiwan Liposome Company Super Generics Major Product Offerings
7.3.4 Taiwan Liposome Company Super Generics Revenue in Global Market (2018-2023)
7.3.5 Taiwan Liposome Company Key News & Latest Developments
7.4 Dr. Reddy?s Laboratories
7.4.1 Dr. Reddy?s Laboratories Company Summary
7.4.2 Dr. Reddy?s Laboratories Business Overview
7.4.3 Dr. Reddy?s Laboratories Super Generics Major Product Offerings
7.4.4 Dr. Reddy?s Laboratories Super Generics Revenue in Global Market (2018-2023)
7.4.5 Dr. Reddy?s Laboratories Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Super Generics Major Product Offerings
7.5.4 Allergan Super Generics Revenue in Global Market (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Company Summary
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Super Generics Major Product Offerings
7.6.4 Teva Pharmaceutical Super Generics Revenue in Global Market (2018-2023)
7.6.5 Teva Pharmaceutical Key News & Latest Developments
7.7 Celgene Corporation
7.7.1 Celgene Corporation Company Summary
7.7.2 Celgene Corporation Business Overview
7.7.3 Celgene Corporation Super Generics Major Product Offerings
7.7.4 Celgene Corporation Super Generics Revenue in Global Market (2018-2023)
7.7.5 Celgene Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Super Generics Market Opportunities & Trends in Global Market
Table 2. Super Generics Market Drivers in Global Market
Table 3. Super Generics Market Restraints in Global Market
Table 4. Key Players of Super Generics in Global Market
Table 5. Top Super Generics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Super Generics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Super Generics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Super Generics Product Type
Table 9. List of Global Tier 1 Super Generics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Super Generics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Super Generics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Super Generics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Super Generics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Super Generics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Super Generics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Super Generics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Super Generics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Super Generics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Super Generics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Super Generics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Super Generics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Super Generics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Super Generics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Super Generics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Super Generics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Super Generics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Super Generics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Super Generics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Super Generics Revenue, (US$, Mn), 2024-2030
Table 30. Sun Pharmaceutical Industries Company Summary
Table 31. Sun Pharmaceutical Industries Super Generics Product Offerings
Table 32. Sun Pharmaceutical Industries Super Generics Revenue (US$, Mn) & (2018-2023)
Table 33. Sun Pharmaceutical Industries Key News & Latest Developments
Table 34. Meda Pharmaceuticals Company Summary
Table 35. Meda Pharmaceuticals Super Generics Product Offerings
Table 36. Meda Pharmaceuticals Super Generics Revenue (US$, Mn) & (2018-2023)
Table 37. Meda Pharmaceuticals Key News & Latest Developments
Table 38. Taiwan Liposome Company Company Summary
Table 39. Taiwan Liposome Company Super Generics Product Offerings
Table 40. Taiwan Liposome Company Super Generics Revenue (US$, Mn) & (2018-2023)
Table 41. Taiwan Liposome Company Key News & Latest Developments
Table 42. Dr. Reddy?s Laboratories Company Summary
Table 43. Dr. Reddy?s Laboratories Super Generics Product Offerings
Table 44. Dr. Reddy?s Laboratories Super Generics Revenue (US$, Mn) & (2018-2023)
Table 45. Dr. Reddy?s Laboratories Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Super Generics Product Offerings
Table 48. Allergan Super Generics Revenue (US$, Mn) & (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. Teva Pharmaceutical Company Summary
Table 51. Teva Pharmaceutical Super Generics Product Offerings
Table 52. Teva Pharmaceutical Super Generics Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Pharmaceutical Key News & Latest Developments
Table 54. Celgene Corporation Company Summary
Table 55. Celgene Corporation Super Generics Product Offerings
Table 56. Celgene Corporation Super Generics Revenue (US$, Mn) & (2018-2023)
Table 57. Celgene Corporation Key News & Latest Developments
List of Figures
Figure 1. Super Generics Segment by Type in 2022
Figure 2. Super Generics Segment by Application in 2022
Figure 3. Global Super Generics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Super Generics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Super Generics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Super Generics Revenue in 2022
Figure 8. By Type - Global Super Generics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Super Generics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Super Generics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Super Generics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Super Generics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Super Generics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Super Generics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Super Generics Revenue Market Share, 2018-2030
Figure 16. US Super Generics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Super Generics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Super Generics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Super Generics Revenue Market Share, 2018-2030
Figure 20. Germany Super Generics Revenue, (US$, Mn), 2018-2030
Figure 21. France Super Generics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Super Generics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Super Generics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Super Generics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Super Generics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Super Generics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Super Generics Revenue Market Share, 2018-2030
Figure 28. China Super Generics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Super Generics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Super Generics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Super Generics Revenue, (US$, Mn), 2018-2030
Figure 32. India Super Generics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Super Generics Revenue Market Share, 2018-2030
Figure 34. Brazil Super Generics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Super Generics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Super Generics Revenue Market Share, 2018-2030
Figure 37. Turkey Super Generics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Super Generics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Super Generics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Super Generics Revenue, (US$, Mn), 2018-2030
Figure 41. Sun Pharmaceutical Industries Super Generics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Meda Pharmaceuticals Super Generics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Taiwan Liposome Company Super Generics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dr. Reddy?s Laboratories Super Generics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Super Generics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Pharmaceutical Super Generics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Celgene Corporation Super Generics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
